Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Every word you type has to appear somewhere in the question, and the closest matches are ranked first.
15,213 questions in 2,394 reviews
current versionsNo studies 15,213 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
FLUPHENAZINE (ORAL) vs RISPERIDONE Adverse effects: Extrapyramidal effects ‐ short/medium term (up to 12 weeks) ‐ not reported · patients with schizophrenia Fluphenazine (oral) versus atypical antipsychotics for schizophrenia (2016) · Cochrane | no estimate extracted | NR | No studies |
FLUPHENAZINE (ORAL) vs RISPERIDONE Cost‐effectiveness (long term) ‐ not reported · patients with schizophrenia Fluphenazine (oral) versus atypical antipsychotics for schizophrenia (2016) · Cochrane | no estimate extracted | NR | No studies |
FLUPHENAZINE (ORAL) vs QUETIAPINE Relapse (long term) · patients with schizophrenia Fluphenazine (oral) versus atypical antipsychotics for schizophrenia (2016) · Cochrane | no estimate extracted | NR | No studies |
FLUPHENAZINE (ORAL) vs QUETIAPINE Clinically important change in life skills (long term) · patients with schizophrenia Fluphenazine (oral) versus atypical antipsychotics for schizophrenia (2016) · Cochrane | no estimate extracted | NR | No studies |
FLUPHENAZINE (ORAL) vs QUETIAPINE Quality of life (long term) · patients with schizophrenia Fluphenazine (oral) versus atypical antipsychotics for schizophrenia (2016) · Cochrane | no estimate extracted | NR | No studies |
FLUPHENAZINE (ORAL) vs QUETIAPINE Adverse effects: Extrapyramidal effects ‐ short/medium term (up to 12 weeks) · patients with schizophrenia Fluphenazine (oral) versus atypical antipsychotics for schizophrenia (2016) · Cochrane | no estimate extracted | NR | No studies |
FLUPHENAZINE (ORAL) vs AMISULPRIDE Relapse (long term) ‐ not reported · patients with schizophrenia Fluphenazine (oral) versus atypical antipsychotics for schizophrenia (2016) · Cochrane | no estimate extracted | NR | No studies |
FLUPHENAZINE (ORAL) vs QUETIAPINE Cost‐effectiveness (long term) · patients with schizophrenia Fluphenazine (oral) versus atypical antipsychotics for schizophrenia (2016) · Cochrane | no estimate extracted | NR | No studies |
FLUPHENAZINE (ORAL) vs OLANZAPINE Relapse (long term) ‐ not reported · patients with schizophrenia Fluphenazine (oral) versus atypical antipsychotics for schizophrenia (2016) · Cochrane | no estimate extracted | NR | No studies |
FLUPHENAZINE (ORAL) vs OLANZAPINE Clinically important change in life skills (long term) ‐ not reported · patients with schizophrenia Fluphenazine (oral) versus atypical antipsychotics for schizophrenia (2016) · Cochrane | no estimate extracted | NR | No studies |
FLUPHENAZINE (ORAL) vs OLANZAPINE Quality of life (long term) ‐ not reported · patients with schizophrenia Fluphenazine (oral) versus atypical antipsychotics for schizophrenia (2016) · Cochrane | no estimate extracted | NR | No studies |
FLUPHENAZINE (ORAL) vs OLANZAPINE Cost‐effectiveness (long term) ‐ not reported · patients with schizophrenia Fluphenazine (oral) versus atypical antipsychotics for schizophrenia (2016) · Cochrane | no estimate extracted | NR | No studies |
FLUPHENAZINE (ORAL) vs AMISULPRIDE Clinically important change in life skills (long term) ‐ not measured · patients with schizophrenia Fluphenazine (oral) versus atypical antipsychotics for schizophrenia (2016) · Cochrane | no estimate extracted | NR | No studies |
FLUPHENAZINE (ORAL) vs AMISULPRIDE Quality of life (long term) ‐ not measured · patients with schizophrenia Fluphenazine (oral) versus atypical antipsychotics for schizophrenia (2016) · Cochrane | no estimate extracted | NR | No studies |
FLUPHENAZINE (ORAL) vs AMISULPRIDE Cost‐effectiveness (long term) ‐ not measured · patients with schizophrenia Fluphenazine (oral) versus atypical antipsychotics for schizophrenia (2016) · Cochrane | no estimate extracted | NR | No studies |
FLUPHENAZINE (ORAL) vs RISPERIDONE Relapse (long term) ‐ not reported · patients with schizophrenia Fluphenazine (oral) versus atypical antipsychotics for schizophrenia (2016) · Cochrane | no estimate extracted | NR | No studies |
Ankle brace vs rigid cast Unacceptable anatomy: leg‐length discrepancy, limp, abnormal gait · children with acute 'low risk' (undisplaced) ankle fractures Interventions for treating ankle fractures in children (2016) · Cochrane | no estimate extracted | NR | No studies |
Minimally invasive surgery vs radiotherapy/chemoradiotherapy Overall survival · patients with small‐volume primary oropharyngeal carcinoma Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small‐volume primary oropharyngeal… (2016) · Cochrane | no estimate extracted | NR | No studies |
Minimally invasive surgery vs radiotherapy/chemoradiotherapy Locoregional control · patients with small‐volume primary oropharyngeal carcinoma Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small‐volume primary oropharyngeal… (2016) · Cochrane | no estimate extracted | NR | No studies |
Minimally invasive surgery vs radiotherapy/chemoradiotherapy Progression‐free survival · patients with small‐volume primary oropharyngeal carcinoma Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small‐volume primary oropharyngeal… (2016) · Cochrane | no estimate extracted | NR | No studies |
Minimally invasive surgery vs radiotherapy/chemoradiotherapy Gastrostomy rate (at 1 year) · patients with small‐volume primary oropharyngeal carcinoma Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small‐volume primary oropharyngeal… (2016) · Cochrane | no estimate extracted | NR | No studies |
Minimally invasive surgery vs radiotherapy/chemoradiotherapy Tracheostomy rate · patients with small‐volume primary oropharyngeal carcinoma Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small‐volume primary oropharyngeal… (2016) · Cochrane | no estimate extracted | NR | No studies |
Minimally invasive surgery vs radiotherapy/chemoradiotherapy Swallowing function (MDADI) · patients with small‐volume primary oropharyngeal carcinoma Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small‐volume primary oropharyngeal… (2016) · Cochrane | no estimate extracted | NR | No studies |
Minimally invasive surgery vs radiotherapy/chemoradiotherapy Quality of life (EORTC QLQ‐C30 and H&N35) · patients with small‐volume primary oropharyngeal carcinoma Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small‐volume primary oropharyngeal… (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Number of days on which bleeding occurred ‐ not reported · people with haematological disorders undergoing intensive chemotherapy or stem cell transplantation Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies… (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Time from randomisation to first bleeding episode ‐ not reported · people with haematological disorders undergoing intensive chemotherapy or stem cell transplantation Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies… (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Number of platelet transfusions ‐ not reported · people with haematological disorders undergoing intensive chemotherapy or stem cell transplantation Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies… (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR All‐cause mortality ‐ not reported · people with haematological disorders undergoing intensive chemotherapy or stem cell transplantation Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies… (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Thromboembolic events ‐ not reported · people with haematological disorders undergoing intensive chemotherapy or stem cell transplantation Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies… (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Quality of life ‐ not reported · people with haematological disorders undergoing intensive chemotherapy or stem cell transplantation Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies… (2016) · Cochrane | no estimate extracted | NR | No studies |
Thrombopoietin mimetics vs placebo or standard care Number of days on which bleeding occurred ‐ not reported · people with haematological disorders undergoing intensive chemotherapy or stem cell transplantation Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies… (2016) · Cochrane | no estimate extracted | NR | No studies |
Thrombopoietin mimetics vs placebo or standard care Time from randomisation to first bleeding episode ‐ not reported · people with haematological disorders undergoing intensive chemotherapy or stem cell transplantation Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies… (2016) · Cochrane | no estimate extracted | NR | No studies |
Thrombopoietin mimetics vs placebo or standard care Quality of life ‐ not reported · people with haematological disorders undergoing intensive chemotherapy or stem cell transplantation Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies… (2016) · Cochrane | no estimate extracted | NR | No studies |
Sexual counselling vs usual care Satisfaction in how sexual issues are addressed in cardiac rehabilitation services (Satisfaction with health services) · participants with cardiovascular disease Sexual counselling for sexual problems in patients with cardiovascular disease (2016) · Cochrane | no estimate extracted | NR | No studies |
Cognitive behaviour therapy vs no treatment Long‐term remission/response ( · adult patients with panic disorder with or without agoraphobia Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta‐analysis (2016) · Cochrane | no estimate extracted | NR | No studies |
PUFA vs Placebo Potential adverse effects ‐ not reported · patients with drug‐resistant epilepsy Polyunsaturated fatty acid supplementation for drug‐resistant epilepsy (2016) · Cochrane | no estimate extracted | NR | No studies |
Breathing exercises as part of a package of interventions vs control Serious adverse events · children with asthma Breathing exercises for children with asthma (2016) · Cochrane | no estimate extracted | NR | No studies |
Technological aid vs internet resource Quality of life ‐ not reported · Children or adolescents with acquired brain injury Technological aids for the rehabilitation of memory and executive functioning in children and adolescents… (2016) · Cochrane | no estimate extracted | NR | No studies |
Technological aid vs internet resource Social functioning ‐ not reported · Children or adolescents with acquired brain injury Technological aids for the rehabilitation of memory and executive functioning in children and adolescents… (2016) · Cochrane | no estimate extracted | NR | No studies |
Technological aid vs internet resource Academic achievement ‐ not reported · Children or adolescents with acquired brain injury Technological aids for the rehabilitation of memory and executive functioning in children and adolescents… (2016) · Cochrane | no estimate extracted | NR | No studies |
Technological aid vs internet resource Adverse events · Children or adolescents with acquired brain injury Technological aids for the rehabilitation of memory and executive functioning in children and adolescents… (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Incidence of wound dehiscence · lower limb arterial surgery Wound drainage for lower limb arterial surgery (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Incidence of reoperation for wound or graft‐related complications · lower limb arterial surgery Wound drainage for lower limb arterial surgery (2016) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Changes in health‐related quality of life · lower limb arterial surgery Wound drainage for lower limb arterial surgery (2016) · Cochrane | no estimate extracted | NR | No studies |
Antibiotics at time of replacement vs no antibiotics at time of replacement Adverse effects (Urinary tract trauma) ‐ not reported · adults with replacing long‐term indwelling urinary catheters Policies for replacing long‐term indwelling urinary catheters in adults (2016) · Cochrane | no estimate extracted | NR | No studies |
Antibiotics at time of replacement vs no antibiotics at time of replacement Formal economic analysis ‐ not reported · adults with replacing long‐term indwelling urinary catheters Policies for replacing long‐term indwelling urinary catheters in adults (2016) · Cochrane | no estimate extracted | NR | No studies |
Sterile water vs 0.05% chlorohexidine gluconate Participant satisfaction ‐ not reported · adults with replacing long‐term indwelling urinary catheters Policies for replacing long‐term indwelling urinary catheters in adults (2016) · Cochrane | no estimate extracted | NR | No studies |
Sterile water vs 0.05% chlorohexidine gluconate Condition‐specific quality of life measures ‐ not reported · adults with replacing long‐term indwelling urinary catheters Policies for replacing long‐term indwelling urinary catheters in adults (2016) · Cochrane | no estimate extracted | NR | No studies |
Sterile water vs 0.05% chlorohexidine gluconate Adverse effects (Urinary tract trauma) ‐ not reported · adults with replacing long‐term indwelling urinary catheters Policies for replacing long‐term indwelling urinary catheters in adults (2016) · Cochrane | no estimate extracted | NR | No studies |
Sterile water vs 0.05% chlorohexidine gluconate Adverse effects (Death) ‐ not reported · adults with replacing long‐term indwelling urinary catheters Policies for replacing long‐term indwelling urinary catheters in adults (2016) · Cochrane | no estimate extracted | NR | No studies |